Listed

Bicycle Therapeutics plc

BCYCNasdaqCIK 1761612HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$34.1m, Q3 FY2026
Operating income−$13.5m, Q3 FY2026
Net income−$10.5m, Q3 FY2026
Bicycle Therapeutics plc, income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m5.3Revenue, Q4 FY2023, three months to 2023-12-31$5.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure19.5Revenue, Q1 FY2024, three months to 2024-03-31$19.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure9.4Revenue, Q2 FY2024, three months to 2024-06-30$9.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure2.7Revenue, Q3 FY2024, three months to 2024-09-30$2.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure3.7Revenue, Q4 FY2024, three months to 2024-12-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure10.0Revenue, Q1 FY2025, three months to 2025-03-31$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure2.9Revenue, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure11.7Revenue, Q3 FY2025, three months to 2025-09-30$11.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure48.0Revenue, Q4 FY2025, three months to 2025-12-31$48.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.9Revenue, Q1 FY2026, three months to 2026-03-31$887.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure0.6Revenue, Q2 FY2026, three months to 2026-06-30$629.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure34.1Revenue, Q3 FY2026, three months to 2026-09-30$34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Research and development$m44.7Research and development, Q4 FY2023, three months to 2023-12-31$44.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure34.9Research and development, Q1 FY2024, three months to 2024-03-31$34.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure40.1Research and development, Q2 FY2024, three months to 2024-06-30$40.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure48.3Research and development, Q3 FY2024, three months to 2024-09-30$48.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure49.8Research and development, Q4 FY2024, three months to 2024-12-31$49.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure59.1Research and development, Q1 FY2025, three months to 2025-03-31$59.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure71.0Research and development, Q2 FY2025, three months to 2025-06-30$71.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure58.4Research and development, Q3 FY2025, three months to 2025-09-30$58.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure51.8Research and development, Q4 FY2025, three months to 2025-12-31$51.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure48.9Research and development, Q1 FY2026, three months to 2026-03-31$48.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure41.2Research and development, Q2 FY2026, three months to 2026-06-30$41.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure33.4Research and development, Q3 FY2026, three months to 2026-09-30$33.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Operating income$m(54.2)Operating income, Q4 FY2023, three months to 2023-12-31−$54.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(31.7)Operating income, Q1 FY2024, three months to 2024-03-31−$31.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure(46.6)Operating income, Q2 FY2024, three months to 2024-06-30−$46.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure(63.8)Operating income, Q3 FY2024, three months to 2024-09-30−$63.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure(67.7)Operating income, Q4 FY2024, three months to 2024-12-31−$67.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(70.2)Operating income, Q1 FY2025, three months to 2025-03-31−$70.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(86.6)Operating income, Q2 FY2025, three months to 2025-06-30−$86.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure(65.6)Operating income, Q3 FY2025, three months to 2025-09-30−$65.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure(24.7)Operating income, Q4 FY2025, three months to 2025-12-31−$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(65.5)Operating income, Q1 FY2026, three months to 2026-03-31−$65.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(54.6)Operating income, Q2 FY2026, three months to 2026-06-30−$54.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure(13.5)Operating income, Q3 FY2026, three months to 2026-09-30−$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Interest expense$m0.8Interest expense, Q4 FY2023, three months to 2023-12-31$820.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-20, accession 0001558370-24-001324. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, Q1 FY2024, three months to 2024-03-31$821.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure0.8Interest expense, Q2 FY2024, three months to 2024-06-30$824.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$33.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$52.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2025-03-31$51.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure0.1Interest expense, Q2 FY2025, three months to 2025-06-30$54.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$44.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure0.1Interest expense, Q4 FY2025, three months to 2025-12-31$57.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$48.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$44.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure0.0Interest expense, Q3 FY2026, three months to 2026-09-30$45.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Income tax$m0.3Income tax, Q4 FY2023, three months to 2023-12-31$320.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Income tax, Q1 FY2024, three months to 2024-03-31−$350.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$115.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure(3.4)Income tax, Q3 FY2024, three months to 2024-09-30−$3.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure(1.1)Income tax, Q4 FY2024, three months to 2024-12-31−$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(1.1)Income tax, Q1 FY2025, three months to 2025-03-31−$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(0.2)Income tax, Q2 FY2025, three months to 2025-06-30−$231.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure0.2Income tax, Q3 FY2025, three months to 2025-09-30$205.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure1.3Income tax, Q4 FY2025, three months to 2025-12-31$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2026, three months to 2026-03-31$172.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$90.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure1.2Income tax, Q3 FY2026, three months to 2026-09-30$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Net income$m(49.1)Net income, Q4 FY2023, three months to 2023-12-31−$49.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(26.6)Net income, Q1 FY2024, three months to 2024-03-31−$26.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure(39.8)Net income, Q2 FY2024, three months to 2024-06-30−$39.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure(50.8)Net income, Q3 FY2024, three months to 2024-09-30−$50.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure(51.9)Net income, Q4 FY2024, three months to 2024-12-31−$51.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(60.8)Net income, Q1 FY2025, three months to 2025-03-31−$60.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure(79.0)Net income, Q2 FY2025, three months to 2025-06-30−$79.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure(59.1)Net income, Q3 FY2025, three months to 2025-09-30−$59.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure(20.2)Net income, Q4 FY2025, three months to 2025-12-31−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(60.8)Net income, Q1 FY2026, three months to 2026-03-31−$60.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure(50.3)Net income, Q2 FY2026, three months to 2026-06-30−$50.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure(10.5)Net income, Q3 FY2026, three months to 2026-09-30−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Diluted EPS$ per sharenot reported(0.62)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure(0.77)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure(0.74)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figurenot reported(0.88)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(1.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure(0.85)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figurenot reported(0.87)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(0.72)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure(0.15)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Basic EPS$ per sharenot reported(0.62)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure(0.77)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure(0.74)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figurenot reported(0.88)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(1.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure(0.85)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figurenot reported(0.87)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(0.72)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure(0.15)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure

Balance sheet

Cash and equivalents$469.9m, Q3 FY2026
Long-term debt$8.5m, Q2 FY2024
Shareholders' equity$505.3m, Q3 FY2026
Bicycle Therapeutics plc, balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m526Cash and equivalents, FY2023, at 2023-12-31$526.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure457Cash and equivalents, Q1 FY2024, at 2024-03-31$457.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure961Cash and equivalents, Q2 FY2024, at 2024-06-30$961.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure891Cash and equivalents, Q3 FY2024, at 2024-09-30$890.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure880Cash and equivalents, FY2024, at 2024-12-31$879.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure793Cash and equivalents, Q1 FY2025, at 2025-03-31$793.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure721Cash and equivalents, Q2 FY2025, at 2025-06-30$721.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure648Cash and equivalents, Q3 FY2025, at 2025-09-30$648.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure628Cash and equivalents, FY2025, at 2025-12-31$628.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure559Cash and equivalents, Q1 FY2026, at 2026-03-31$559.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure510Cash and equivalents, Q2 FY2026, at 2026-06-30$510.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure470Cash and equivalents, Q3 FY2026, at 2026-09-30$469.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Current assets$m562Current assets, FY2023, at 2023-12-31$561.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001558370-25-001438.Report this figure516Current assets, Q1 FY2024, at 2024-03-31$516.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure1,028Current assets, Q2 FY2024, at 2024-06-30$1.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figure966Current assets, Q3 FY2024, at 2024-09-30$966.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001558370-24-014004.Report this figure929Current assets, FY2024, at 2024-12-31$928.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure856Current assets, Q1 FY2025, at 2025-03-31$856.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure804Current assets, Q2 FY2025, at 2025-06-30$804.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure739Current assets, Q3 FY2025, at 2025-09-30$738.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure683Current assets, FY2025, at 2025-12-31$682.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure619Current assets, Q1 FY2026, at 2026-03-31$619.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure575Current assets, Q2 FY2026, at 2026-06-30$575.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure538Current assets, Q3 FY2026, at 2026-09-30$537.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Total assets$m595Total assets, FY2023, at 2023-12-31$595.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001558370-25-001438.Report this figure547Total assets, Q1 FY2024, at 2024-03-31$547.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure1,057Total assets, Q2 FY2024, at 2024-06-30$1.06bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figure997Total assets, Q3 FY2024, at 2024-09-30$996.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001558370-24-014004.Report this figure957Total assets, FY2024, at 2024-12-31$956.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure884Total assets, Q1 FY2025, at 2025-03-31$883.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure832Total assets, Q2 FY2025, at 2025-06-30$832.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure764Total assets, Q3 FY2025, at 2025-09-30$764.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure718Total assets, FY2025, at 2025-12-31$717.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure652Total assets, Q1 FY2026, at 2026-03-31$652.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure607Total assets, Q2 FY2026, at 2026-06-30$606.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure567Total assets, Q3 FY2026, at 2026-09-30$567.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Current liabilities$m69.5Current liabilities, FY2023, at 2023-12-31$69.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001558370-25-001438.Report this figure49.5Current liabilities, Q1 FY2024, at 2024-03-31$49.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure69.6Current liabilities, Q2 FY2024, at 2024-06-30$69.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figure56.4Current liabilities, Q3 FY2024, at 2024-09-30$56.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001558370-24-014004.Report this figure67.2Current liabilities, FY2024, at 2024-12-31$67.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure57.6Current liabilities, Q1 FY2025, at 2025-03-31$57.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure77.4Current liabilities, Q2 FY2025, at 2025-06-30$77.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure69.3Current liabilities, Q3 FY2025, at 2025-09-30$69.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure57.0Current liabilities, FY2025, at 2025-12-31$57.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure48.9Current liabilities, Q1 FY2026, at 2026-03-31$48.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure47.6Current liabilities, Q2 FY2026, at 2026-06-30$47.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure44.5Current liabilities, Q3 FY2026, at 2026-09-30$44.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Total liabilities$m224Total liabilities, FY2023, at 2023-12-31$224.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001558370-25-001438.Report this figure191Total liabilities, Q1 FY2024, at 2024-03-31$191.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure184Total liabilities, Q2 FY2024, at 2024-06-30$183.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figure166Total liabilities, Q3 FY2024, at 2024-09-30$165.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001558370-24-014004.Report this figure164Total liabilities, FY2024, at 2024-12-31$163.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure144Total liabilities, Q1 FY2025, at 2025-03-31$143.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure163Total liabilities, Q2 FY2025, at 2025-06-30$163.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure145Total liabilities, Q3 FY2025, at 2025-09-30$145.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure108Total liabilities, FY2025, at 2025-12-31$107.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure98.1Total liabilities, Q1 FY2026, at 2026-03-31$98.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure96.3Total liabilities, Q2 FY2026, at 2026-06-30$96.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure61.9Total liabilities, Q3 FY2026, at 2026-09-30$61.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure
Long-term debt$m30.7Long-term debt, FY2023, at 2023-12-31$30.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-25, accession 0001558370-25-001438.Report this figure30.8Long-term debt, Q1 FY2024, at 2024-03-31$30.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure8.5Long-term debt, Q2 FY2024, at 2024-06-30$8.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reported22.4Current portion of debt, Q2 FY2024, at 2024-06-30$22.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m371Shareholders' equity, FY2023, at 2023-12-31$370.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-17, accession 0001104659-26-028971.Report this figure356Shareholders' equity, Q1 FY2024, at 2024-03-31$356.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure874Shareholders' equity, Q2 FY2024, at 2024-06-30$873.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure831Shareholders' equity, Q3 FY2024, at 2024-09-30$831.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure793Shareholders' equity, FY2024, at 2024-12-31$793.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure740Shareholders' equity, Q1 FY2025, at 2025-03-31$740.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure669Shareholders' equity, Q2 FY2025, at 2025-06-30$668.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure618Shareholders' equity, Q3 FY2025, at 2025-09-30$618.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure610Shareholders' equity, FY2025, at 2025-12-31$610.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure554Shareholders' equity, Q1 FY2026, at 2026-03-31$554.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure510Shareholders' equity, Q2 FY2026, at 2026-06-30$510.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure505Shareholders' equity, Q3 FY2026, at 2026-09-30$505.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure

Cash flow

Operating cash flow−$40.3m, Q3 FY2026
Capital expenditure$305.0k, Q3 FY2026
Bicycle Therapeutics plc, cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(47.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$47.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(70.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$70.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure(44.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$44.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001558370-25-010843. Derived: 6-month figure less the 3-month figure.Report this figure(39.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$39.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001104659-25-104010. Derived: 9-month figure less the 6-month figure.Report this figure(9.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(86.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$86.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(72.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$72.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001104659-26-088457. Derived: 6-month figure less the 3-month figure.Report this figure(71.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$71.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001104659-26-119864. Derived: 9-month figure less the 6-month figure.Report this figure(19.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure(65.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$65.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure(49.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$49.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001104659-26-088457. Derived: 6-month figure less the 3-month figure.Report this figure(40.3)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$40.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001104659-26-119864. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure0.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$420.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001558370-25-010843. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$435.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001104659-25-104010. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2024, three months to 2024-12-31$368.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$604.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure0.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$498.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001104659-26-088457. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2025, three months to 2025-09-30$674.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001104659-26-119864. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$574.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001104659-26-028971. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$713.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure0.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$265.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001104659-26-088457. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2026, three months to 2026-09-30$305.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001104659-26-119864. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)69.98m, Q3 FY2026
Bicycle Therapeutics plc, shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares30.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3130,001,725 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001558370-24-006453.Report this figure30.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3030,191,693 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001558370-24-010949.Report this figure39.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3039,576,467 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001558370-24-014004.Report this figure42.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3142,560,091 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001558370-25-006049.Report this figure52.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3051,992,034 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001558370-25-010843.Report this figure69.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3068,988,858 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001104659-25-104010.Report this figure69.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3169,196,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure69.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3069,252,009 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure69.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3069,303,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure69.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3169,683,471 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001104659-26-052117.Report this figure69.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3069,804,828 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001104659-26-088457.Report this figure70.0Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3069,979,934 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001104659-26-119864.Report this figure

Shares outstanding: 30.04mShares outstanding, period not labelled, at 2023-05-0130,043,486 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2023-05-04, accession 0001558370-23-007979.Report this figure at May 1, 2023, from the cover of the 10-Q filed May 4, 2023.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:25 ET. Listed shows no prices and gives no investment advice.